Sector ETF report for SBIO
Why Is ALPS Medical Breakthroughs ETF (SBIO) Stock Down Today?
Updated Nov 17, 2026 8:29 AM ET · Prev Close $55.63
Session Regime & Catalyst Assessment
68% Signal ConvictionALPS Medical Breakthroughs ETF Pulling Back 3.17% on 0.73x Relative Volume
ALPS Medical Breakthroughs ETF (Sbio) is pulling back 3.17% (-$1.76) to $53.87 on 0.73x average session volume. Relative to benchmarks, SBIO is lagging the S&P 500 by -1.26%. 14-day RSI stands at 44.2, keeping momentum in a bearish regime.
Sector ETF report for SBIO
Price ($53.87) trades relative to 20-day SMA ($55.23) and 50-day SMA ($57.04).
Market & Sector Relative Strength
SBIO lagging the S&P 500 by -1.26%Recent SBIO Catalyst Headlines
Verified WireCreator TV , the creator-led streaming network and content studio owned and operated by Sabio Holdings Tsxv Sbio Otcqb Sabof , today announced that the Creator Tv Fast channel is now available on VIZIO's free-ad supporte
Sabio Holdings, a Los Angeles-based creator-led, data-driven and AI-powered AdTech company helping global brands reach, engage and validate R.E.V. streaming TV audiences, and Gentoro, an enterprise AI company focused on
Sabio Holdings Inc. Tsxv Sbio Otcqb Sabof the Company or Sabio , a Los Angeles-based creator-led, data-driven and AI-powered ad-tech company helping global brands reach, engage and validate R.E.V. streaming TV audiences,
1–3 Day Expected Range & Key Level
48% Follow-ThroughMonitor volume expansion above 1.5x RVOL around $55.23 (20-day SMA resistance) for directional breakout confirmation.
Technical Regime (SBIO)
BEARISH MA TRENDRetail & Crowd Sentiment
NeutralAbout ALPS Medical Breakthroughs ETF
Get Instant SBIO Catalyst Alerts
Receive an email alert when SBIO triggers an unusual volume breakout, options sweep, or rating shift.
Other Liquid Stocks Moving Today
All Today's MoversSBIO Session & Catalyst FAQ
Why is SBIO stock down today?
ALPS Medical Breakthroughs ETF (Sbio) is pulling back 3.17% (-$1.76) to $53.87 on 0.73x average session volume. Relative to benchmarks, SBIO is lagging the S&P 500 by -1.26%. 14-day RSI stands at 44.2, keeping momentum in a bearish regime.
Is SBIO stock a buy or sell right now?
Today's session carries a 68% catalyst conviction score on 0.73x relative volume (low participation). Our multi-factor model currently rates SBIO as HOLD. Review full valuation, quality, and timing signals on the SBIO Buy or Sell Decision Brief →
What is SBIO's intrinsic value and expected trading range?
At $53.87, SBIO's modeled 1-to-3 session range is $50.91 – $56.83, with a key inflection level at $55.23 (20-day SMA resistance). Compare current price against multi-year cash flow projections in the SBIO Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →
What do RSI and moving averages signal for SBIO?
RSI at 44.2 reflects soft below-midline momentum. SBIO trades at $53.87 relative to its 20-day SMA ($55.23) and 50-day SMA ($57.04), reflecting a bearish moving-average structure.
Tradestie Flagship Research & Market Hubs
Live institutional catalyst tape ranking liquid gainers, losers, options sweeps, and RVOL surges.
Track spot H100/B200 compute rental rates and frontier LLM inference token economics.
Wafer yield, CoWoS packaging, and HBM bill-of-materials teardown models across AI accelerators.
Monitor engineering velocity and upstream foundry wafer demand inflections across tech leaders.
Live conviction tracking, invalidation guardrails, and thesis health checks on flagship ideas.
Backtest-validated unusual options positioning and open-interest accumulation setups.
Daily ranked quantitative leaderboard with audited forward-return track record vs S&P 500.
High-yield, quality-screened cash-secured put and put-spread income candidates.